Jacob A, McKeon A, Nakashima I, Sato DK, Elsone L, Fujihara K, De Seze J: Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. J Neurol Neurosurg Psychiatry 2013, 84(8):922–930. doi:10.1136/jnnp-2012–302310
Article
PubMed
Google Scholar
Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B: Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 2008, 4(4):202–214. doi:10.1038/ncpneuro0764
CAS
PubMed
Google Scholar
Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG: The spectrum of neuromyelitis optica. Lancet Neurol 2007, 6(9):805–815. doi:S1474–4422(07)70216–8 10.1016/S1474-4422(07)70216-8
Article
CAS
PubMed
Google Scholar
Jarius S, Wildemann B: AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 2010, 6(7):383–392. doi:10.1038/nrneurol.2010.72 10.1038/nrneurol.2010.72
Article
CAS
PubMed
Google Scholar
Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR: IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202(4):473–477. doi:jem.20050304 10.1084/jem.20050304
Article
CAS
PubMed
PubMed Central
Google Scholar
Papadopoulos MC, Verkman AS: Aquaporin water channels in the nervous system. Nat Rev Neurosci 2013, 14(4):265–277. doi:10.1038/nrn3468 10.1038/nrn3468
Article
CAS
PubMed
PubMed Central
Google Scholar
Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP: Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 1997, 17(1):171–180.
CAS
PubMed
Google Scholar
Frigeri A, Gropper MA, Turck CW, Verkman AS: Immunolocalization of the mercurial-insensitive water channel and glycerol intrinsic protein in epithelial cell plasma membranes. Proc Natl Acad Sci U S A 1995, 92(10):4328–4331. 10.1073/pnas.92.10.4328
Article
CAS
PubMed
PubMed Central
Google Scholar
Frigeri A, Gropper MA, Umenishi F, Kawashima M, Brown D, Verkman AS: Localization of MIWC and GLIP water channel homologs in neuromuscular, epithelial and glandular tissues. J Cell Sci 1995, 108(Pt 9):2993–3002.
CAS
PubMed
Google Scholar
Papadopoulos MC, Verkman AS: Aquaporin 4 and neuromyelitis optica. Lancet Neurol 2012, 11(6):535–544. doi:10.1016/S1474–4422(12)70133–3 10.1016/S1474-4422(12)70133-3
Article
CAS
PubMed
PubMed Central
Google Scholar
Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF: Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007, 130(Pt 5):1194–1205. doi:awl371
Article
PubMed
Google Scholar
Hengstman GJ, Wesseling P, Frenken CW, Jongen PJ: Neuromyelitis optica with clinical and histopathological involvement of the brain. Mult Scler 2007, 13(5):679–682. doi:1352458506070145 10.1177/1352458506070145
Article
CAS
PubMed
Google Scholar
Kira J: Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders. J Neurol Sci 2011, 311(1–2):69–77. doi:10.1016/j.jns.2011.08.043
Article
CAS
PubMed
Google Scholar
Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y: Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007, 130(Pt 5):1224–1234. doi:awm047
Article
CAS
PubMed
Google Scholar
Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H: A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 2002, 125(Pt 7):1450–1461.
Article
PubMed
Google Scholar
Ratelade J, Asavapanumas N, Ritchie AM, Wemlinger S, Bennett JL, Verkman AS: Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica. Acta Neuropathol 2013, 126(5):699–709. doi:10.1007/s00401–013–1172-z 10.1007/s00401-013-1172-z
Article
PubMed
PubMed Central
Google Scholar
Pohl M, Kawakami N, Kitic M, Bauer J, Martins R, Fischer MT, Machado-Santos J, Mader S, Ellwart JW, Misu T, Fujihara K, Wekerle H, Reindl M, Lassmann H, Bradl M: T cell-activation in neuromyelitis optica lesions plays a role in their formation. Acta Neuropathol Commun 2013, 1(1):85. doi:10.1186/2051–5960–1-85 10.1186/2051-5960-1-85
Article
PubMed
PubMed Central
Google Scholar
Kitic M, Hochmeister S, Wimmer I, Bauer J, Misu T, Mader S, Reindl M, Fujihara K, Lassmann H, Bradl M: Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats. Acta Neuropathol Commun 2013, 1(1):5. doi:10.1186/2051–5960–1-5 10.1186/2051-5960-1-5
Article
PubMed
PubMed Central
Google Scholar
Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC: Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010, 133(Pt 2):349–361. doi:10.1093/brain/awp309
Article
PubMed
PubMed Central
Google Scholar
Jones MV, Collongues N, De Seze J, Kinoshita M, Nakatsuji Y, Levy M: Review of animal models of neuromyelitis optica. Mult Scler Relat Disord 2012, 1(4):174–179. doi:10.1016/j.msard.2012.06.003 10.1016/j.msard.2012.06.003
Article
PubMed
PubMed Central
Google Scholar
Bradl M, Lassmann H: Experimental models of neuromyelitis optica. Brain Pathol 2014, 24(1):74–82. doi:10.1111/bpa.12098 10.1111/bpa.12098
Article
CAS
PubMed
Google Scholar
Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, Glogowska M, Case D, Antel JP, Owens GP, Gilden D, Nessler S, Stadelmann C, Hemmer B: Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009, 66(5):617–629. doi:10.1002/ana.21802 10.1002/ana.21802
Article
CAS
PubMed
PubMed Central
Google Scholar
Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, Adzemovic M, Bauer J, Berger T, Fujihara K, Itoyama Y, Lassmann H: Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009, 66(5):630–643. doi:10.1002/ana.21837 10.1002/ana.21837
Article
CAS
PubMed
Google Scholar
Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, Kumanogoh A, Kajiyama K, Yoshikawa H, Sakoda S: Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun 2009, 386(4):623–627. doi:10.1016/j.bbrc.2009.06.085 10.1016/j.bbrc.2009.06.085
Article
CAS
PubMed
Google Scholar
Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, Kumanogoh A, Kajiyama K, Yoshikawa H, Sakoda S: Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells. Biochem Biophys Res Commun 2010, 394(1):205–210. doi:10.1016/j.bbrc.2010.02.157 10.1016/j.bbrc.2010.02.157
Article
CAS
PubMed
Google Scholar
Ratelade J, Zhang H, Saadoun S, Bennett JL, Papadopoulos MC, Verkman AS: Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss. Acta Neuropathol 2012, 123(6):861–872. doi:10.1007/s00401–012–0986–4 10.1007/s00401-012-0986-4
Article
CAS
PubMed
PubMed Central
Google Scholar
Saadoun S, Waters P, MacDonald C, Bell BA, Vincent A, Verkman AS, Papadopoulos MC: Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain. Ann Neurol 2012, 71(3):323–333. doi:10.1002/ana.22686 10.1002/ana.22686
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang H, Bennett JL, Verkman AS: Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. Ann Neurol 2011, 70(6):943–954. doi:10.1002/ana.22551 10.1002/ana.22551
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang H, Verkman AS: Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica. J Clin Invest 2013, 123(5):2306–2316. doi:10.1172/JCI67554 10.1172/JCI67554
Article
CAS
PubMed
PubMed Central
Google Scholar
Asavapanumas N, Ratelade J, Papadopoulos MC, Bennett JL, Levin MH, Verkman AS: Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G. J Neuroinflammation 2014, 11: 16. doi:10.1186/1742–2094–11–16 10.1186/1742-2094-11-16
Article
PubMed
PubMed Central
Google Scholar
Zhang H, Verkman AS: Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59. J Autoimmun 2014. doi: 10.1016/j.jaut.2014.02.011. [Epub ahead of print]
Google Scholar
Bergman I, Basse PH, Barmada MA, Griffin JA, Cheung NK: Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors. Cancer Immunol Immunother 2000., 49:
Google Scholar
Asavapanumas N, Ratelade J, Verkman AS: Unique neuromyelitis optica pathology produced in naive rats by intracerebral administration of NMO-IgG. Acta Neuropathol 2014, 127(4):539–551. doi:10.1007/s00401–013–1204–8 10.1007/s00401-013-1204-8
Article
CAS
PubMed
Google Scholar
Tradtrantip L, Zhang H, Saadoun S, Phuan PW, Lam C, Papadopoulos MC, Bennett JL, Verkman AS: Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol 2012, 71(3):314–322. doi:10.1002/ana.22657 10.1002/ana.22657
Article
CAS
PubMed
PubMed Central
Google Scholar
Tradtrantip L, Ratelade J, Zhang H, Verkman AS: Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody. Ann Neurol 2013, 73(1):77–85. doi:10.1002/ana.23741 10.1002/ana.23741
Article
CAS
PubMed
Google Scholar
Tradtrantip L, Asavapanumas N, Verkman AS: Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinase. Mol Pharmacol 2013, 83(6):1268–1275. doi:10.1124/mol.113.086470 10.1124/mol.113.086470
Article
CAS
PubMed
PubMed Central
Google Scholar
Phuan PW, Zhang H, Asavapanumas N, Leviten M, Rosenthal A, Tradtrantip L, Verkman AS: C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica. Acta Neuropathol 2013, 125(6):829–840. doi:10.1007/s00401–013–1128–3 10.1007/s00401-013-1128-3
Article
CAS
PubMed
PubMed Central
Google Scholar
Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O’Toole O, Wingerchuk DM: Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol 2013, 12(6):554–562. doi:10.1016/S1474–4422(13)70076–0 10.1016/S1474-4422(13)70076-0
Article
CAS
PubMed
Google Scholar
Crane JM, Lam C, Rossi A, Gupta T, Bennett JL, Verkman AS: Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays. J Biol Chem 2011, 286(18):16516–16524. doi:10.1074/jbc.M111.227298 10.1074/jbc.M111.227298
Article
CAS
PubMed
PubMed Central
Google Scholar
Phuan PW, Ratelade J, Rossi A, Tradtrantip L, Verkman AS: Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays. J Biol Chem 2012, 287(17):13829–13839. doi:10.1074/jbc.M112.344325 10.1074/jbc.M112.344325
Article
CAS
PubMed
PubMed Central
Google Scholar
Levin ME, Jin JG, Ji RR, Tong J, Pomonis JD, Lavery DJ, Miller SW, Chiang LW: Complement activation in the peripheral nervous system following the spinal nerve ligation model of neuropathic pain. Pain 2008, 137(1):182–201. doi:S0304–3959(07)00672–0 10.1016/j.pain.2007.11.005
Article
CAS
PubMed
Google Scholar
Vogel CW, Fritzinger DC: Cobra venom factor: Structure, function, and humanization for therapeutic complement depletion. Toxicon 2010, 56(7):1198–1222. doi:10.1016/j.toxicon.2010.04.007 10.1016/j.toxicon.2010.04.007
Article
CAS
PubMed
Google Scholar
Ratelade J, Bennett JL, Verkman AS: Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema. PLoS One 2011, 6(11):e27412. doi:10.1371/journal.pone.0027412 10.1371/journal.pone.0027412
Article
CAS
PubMed
PubMed Central
Google Scholar
Singhrao SK, Neal JW, Rushmere NK, Morgan BP, Gasque P: Differential expression of individual complement regulators in the brain and choroid plexus. Lab Invest 1999, 79(10):1247–1259.
CAS
PubMed
Google Scholar
Baalasubramanian S, Harris CL, Donev RM, Mizuno M, Omidvar N, Song WC, Morgan BP: CD59a is the primary regulator of membrane attack complex assembly in the mouse. J Immunol 2004, 173(6):3684–3692. doi:173/6/3684 10.4049/jimmunol.173.6.3684
Article
CAS
PubMed
Google Scholar
Van Beek J, Van Meurs M, t Hart BA, Brok HP, Neal JW, Chatagner A, Harris CL, Omidvar N, Morgan BP, Laman JD, Gasque P: Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation. J Immunol 2005, 174(4):2353–2365. doi:174/4/2353 10.4049/jimmunol.174.4.2353
Article
CAS
PubMed
Google Scholar
Gelderman KA, Zijlmans HJ, Vonk MJ, Gorter A: CD55 expression patterns on intestinal neuronal tissue are divergent from the brain. Gut 2004, 53(4):507–513. 10.1136/gut.2003.026773
Article
CAS
PubMed
PubMed Central
Google Scholar
Nishiyama S, Ito T, Misu T, Takahashi T, Kikuchi A, Suzuki N, Jin K, Aoki M, Fujihara K, Itoyama Y: A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology 2009, 72(22):1960–1961. doi:10.1212/WNL.0b013e3181a82621 10.1212/WNL.0b013e3181a82621
Article
CAS
PubMed
Google Scholar
Tradtrantip L, Zhang H, Anderson MO, Saadoun S, Phuan PW, Papadopoulos MC, Bennett JL, Verkman AS: Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica. FASEB J 2012, 26(5):2197–2208. doi:10.1096/fj.11–201608 10.1096/fj.11-201608
Article
CAS
PubMed
PubMed Central
Google Scholar